These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7526100)

  • 41. Intracellular translocation of endothelial nitric oxide synthase by lysophosphatidylcholine.
    Dudek R; Wildhirt S; Suzuki H; Winder S; Bing RJ
    Pharmacology; 1995 Apr; 50(4):257-60. PubMed ID: 7540765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial nitric oxide synthase (Nos3) maps to the proximal region of mouse chromosome 5.
    Gregg AR; Lee CG; Herman GE; O'Brien WE
    Mamm Genome; 1995 Feb; 6(2):152. PubMed ID: 7539311
    [No Abstract]   [Full Text] [Related]  

  • 43. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase.
    Michel T; Li GK; Busconi L
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6252-6. PubMed ID: 7687064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide synthase (NOS) in the human umbilical cord vessels. An immunohistochemical study.
    Dikranian K; Trosheva M; Nikolov S; Bodin P
    Acta Histochem; 1994 Jun; 96(2):145-53. PubMed ID: 7526585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.
    Radomski MW; Palmer RM; Moncada S
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):10043-7. PubMed ID: 1702214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isoforms of nitric oxide synthase. Characterization and purification from different cell types.
    Förstermann U; Schmidt HH; Pollock JS; Sheng H; Mitchell JA; Warner TD; Nakane M; Murad F
    Biochem Pharmacol; 1991 Oct; 42(10):1849-57. PubMed ID: 1720618
    [No Abstract]   [Full Text] [Related]  

  • 47. Activation of nitric oxide synthase from cultured aortic endothelial cells by phospholipids.
    Ohashi Y; Katayama M; Hirata K; Suematsu M; Kawashima S; Yokoyama M
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1314-20. PubMed ID: 7692845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitric oxide synthases in mammals.
    Knowles RG; Moncada S
    Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):249-58. PubMed ID: 7510950
    [No Abstract]   [Full Text] [Related]  

  • 49. A commentary: inducible nitric oxide synthase.
    Nathan C
    Res Immunol; 1991 Sep; 142(7):600-2. PubMed ID: 1725935
    [No Abstract]   [Full Text] [Related]  

  • 50. [On the histotopy of enzymes of energy producing metabolism in the epidermis in psoriasis vulgaris].
    Braun-Falco O; Petzoldt D
    Arch Klin Exp Dermatol; 1967; 230(3):223-38. PubMed ID: 5599872
    [No Abstract]   [Full Text] [Related]  

  • 51. [Current knowledge on the formation of nitric oxide in endothelial cells of blood vessels, in nerve cells and macrophages as well as its significance in vascular dilatation, information transmission and damage of tumor cells].
    Kolb E
    Z Gesamte Inn Med; 1991 Aug; 46(12):431-6. PubMed ID: 1719706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel neuronal messenger molecule in brain: the free radical, nitric oxide.
    Dawson TM; Dawson VL; Snyder SH
    Ann Neurol; 1992 Sep; 32(3):297-311. PubMed ID: 1384420
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aminoguanidine selectively inhibits inducible nitric oxide synthase.
    Griffiths MJ; Messent M; MacAllister RJ; Evans TW
    Br J Pharmacol; 1993 Nov; 110(3):963-8. PubMed ID: 7507781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nitric oxide synthases in neuronal cells, macrophages and endothelium are NADPH diaphorases, but represent only a fraction of total cellular NADPH diaphorase activity.
    Tracey WR; Nakane M; Pollock JS; Förstermann U
    Biochem Biophys Res Commun; 1993 Sep; 195(2):1035-40. PubMed ID: 7690549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nitric oxide and homeostasis of the smooth vascular muscle].
    Schini VB; Vanhoutte PM
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():83-9. PubMed ID: 7692833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nitric oxide and hypoxic pulmonary hypertension.
    Leeman M; Naeije R
    Eur Respir J; 1995 Apr; 8(4):513-4. PubMed ID: 7545132
    [No Abstract]   [Full Text] [Related]  

  • 57. Purification and characterization of the constitutive nitric oxide synthase from human placenta.
    Garvey EP; Tuttle JV; Covington K; Merrill BM; Wood ER; Baylis SA; Charles IG
    Arch Biochem Biophys; 1994 Jun; 311(2):235-41. PubMed ID: 7515611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
    Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The L-arginine-nitric oxide pathway.
    Moncada S; Higgs A
    N Engl J Med; 1993 Dec; 329(27):2002-12. PubMed ID: 7504210
    [No Abstract]   [Full Text] [Related]  

  • 60. Psoriasis associated with human immunodeficiency virus in an infant.
    McAleer P; Chu P; White SM; Don PC; Bamji M; Weinberg JM
    Pediatr Dermatol; 1999; 16(2):144-5. PubMed ID: 10337681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.